Alzheimer’s Matters, the official blog of the ADDF, features insights, perspectives and commentary on current topics of interest in Alzheimer’s disease and related drug discovery.

Research Update: Dr. Carmela Abraham Founds New Biotech


With support from the ADDF, Carmela Abraham, PhD, recently founded a biotech company to accelerate the development of a new class of drugs to combat Alzheimer’s disease

Alzheimer’s Drug Featured in Time Was Made Possible by the ADDF


Grantee Dr. Frank Longo's promising new drug to treat Alzheimer's is on the cover of Time magazine

2015: Our Most Successful Year


Executive Director Howard Fillit, MD, looks back at 2015—our most successful year ever—and thanks the supporters and scientists who made it possible

The Richness of Memory


Planning holidays and other celebrations is challenging when a loved one has dementia. Adam Rowe shares his experience with planning his parents' 50th anniversary while accommodating limitations caused by his mother's frontotemporal dementia.

Giving Tuesday


For #GivingTuesday 2015, we invite you learn more about our critical work to conquer Alzheimer's. 

Allison Johnson: A Runner’s Story


Allison Johnson, a member of or first official TCS New York City Marathon team, shares why she's running for Alzheimer's

Investing in a Cure


Investing more in drug discovery and development is the best chance we have for finding a cure for Alzheimer's disease. Our Executive Director Dr. Howard Fillit explains why. 

Adam Rowe Reflects: A Mother’s Voice


A mother's voice is the first thing we hear from the time we exit the womb. And its the voice we continue to hear throughout our lives. We model our mother's voice when we first learn to talk. The same voice guides us as we begin to walk. It warns you of potential harm and radiates warmth when you need consolation. It's because this voice commands such power, that it's even more devastating when Alzheimer's disease quiets it. Or silences it completely. 

Partners for a Cure: Association for Frontotemporal Dementia


Have you ever wondered why the Alzheimer’s Drug Discovery Foundation (ADDF) puts such a premium on partnerships? It’s because we know that when we team up with other forward-thinking foundations we increase our funding power and our combined expertise—ultimately, ensuring that we can get to a cure for Alzheimer’s and related dementias faster.  

Parents Need Answers About Youth Sports Concussions


When 49ers inside linebacker Chris Borland announced his early retirement from the NFL after just one season, the league and fans reacted with shock. But as a father, a neuroscientist and a geriatrician, I can imagine all too well the immense relief that Borland's parents likely felt knowing they would no longer have to watch their son take a beating on Sunday afternoons.